trending Market Intelligence /marketintelligence/en/news-insights/trending/z3sddh1UZmdlpmN1dSbdgA2 content esgSubNav
In This List

Gemphire CEO resigns; interim replacement named

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


Gemphire CEO resigns; interim replacement named

Mina Sooch resigned as president, CEO and director of Gemphire Therapeutics Inc. due to personal reasons, effective May 23.

Steven Gullans, a board member since April 2016, has been named interim president and CEO until a search for a replacement is completed.

Gullans is a managing director at venture capital firm Excel Venture Management LLC, which owns more than 5% of Gemphire's outstanding common stock.